| Literature DB >> 34859101 |
Weilu Mu1,2, Junlin Zhou1.
Abstract
OBJECTIVE: To analyze the effect of PFNA-II internal fixation on hip joint recovery and quality of life (QOL) in patients with lateral-wall dangerous type of intertrochanteric fracture.Entities:
Mesh:
Year: 2021 PMID: 34859101 PMCID: PMC8632387 DOI: 10.1155/2021/5911868
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Comparison of general data between PFNA group and DHS group.
| Factors | PFNA group ( | DHS group ( |
|
|
|---|---|---|---|---|
| Age (years old) | 67.43 ± 5.32 | 68.26 ± 6.24 | 0.760 | 0.449 |
| Gender | 0.012 | 0.913 | ||
| Male | 25 (42.37) | 23 (43.4) | ||
| Female | 34 (57.63) | 30 (56.6) | ||
| Cause of injury | 1.983 | 0.159 | ||
| Fall | 42 (71.19) | 31 (58.49) | ||
| Collision | 17 (28.81) | 22 (41.51) | ||
| Time between operation and injury (day) | 5.23 ± 1.41 | 4.87 ± 1.39 | 1.358 | 0.177 |
| Fracture type | 0.304 | 0.581 | ||
| Open | 14 (23.73) | 15 (28.3) | ||
| Closed | 45 (76.27) | 38 (71.7) | ||
| AO classification of fracture | 0.373 | 0.830 | ||
| A1 | 14 (23.73) | 19 (35.85) | ||
| A2 | 23 (38.98) | 22 (41.51) | ||
| A3 | 12 (20.34) | 12 (22.64) | ||
| Tronzo-Evans classification | 1.439 | 0.837 | ||
| I | 5 (8.47) | 6 (11.32) | ||
| II | 16 (27.12) | 13 (24.53) | ||
| III | 13 (22.03) | 18 (33.96) | ||
| IV | 10 (16.95) | 9 (16.98) | ||
| V | 5 (8.47) | 7 (13.21) | ||
| Underlying comorbidities | 0.168 | 0.682 | ||
| Hypertension | 10 (16.95) | 13 (24.53) | ||
| Coronary heart disease | 7 (11.86) | 12 (22.64) | ||
| Diabetes mellitus | 6 (10.17) | 7 (13.21) | ||
| Chronic lung disease | 3 (5.08) | 3 (5.66) | ||
| Others | 4 (6.78) | 5 (9.43) |
Abbreviation: PFNA: proximal femoral nail antirotation; DHS: dynamic hip screw group.
Comparison of clinical indicators between the two groups (x ± sd).
| Groups |
| Operation time | Intraoperative blood loss (mL) | Postoperative drainage volume (mL) |
|---|---|---|---|---|
| PFNA group | 59 | 54.94 ± 7.29 | 119.69 ± 19.43 | 72.10 ± 14.12 |
| DHS group | 53 | 61.17 ± 6.45 | 130.64 ± 18.75 | 81.13 ± 15.76 |
|
| — | 4.767 | 3.027 | 3.198 |
|
| — | <0.001 | 0.003 | 0.002 |
Abbreviation: PFNA: proximal femoral nail antirotation; DHS: dynamic hip screw group.
Incidence of postoperative complications in PFNA group and DHS group (n (%)).
| Groups |
| Incision infection | Bedsore | Delayed fracture healing | Deep vein thrombosis | Lung infection | Urinary infection | Total adverse reactions |
|---|---|---|---|---|---|---|---|---|
| PFNA group | 59 | 0 (0.00) | 1 (1.69) | 0 (0.00) | 0 (0.00) | 1 (1.69) | 0 (0.00) | 2 (3.38) |
| DHS group | 53 | 1 (1.89) | 3 (5.66) | 1 (1.89) | 1 (1.89) | 2 (3.77) | 1 (1.89) | 9 (16.99) |
|
| — | — | — | — | — | — | — | 5.823 |
|
| — | — | — | — | — | — | — | 0.016 |
Abbreviation: PFNA: proximal femoral nail antirotation; DHS: dynamic hip screw group.
Comparison of therapeutic effect between the two groups (x ± sd).
| Groups |
| Excellent | Good | Fair | Poor | Excellent and good |
|---|---|---|---|---|---|---|
| PFNA group | 59 | 20 (33.90) | 29 (49.15) | 6 (10.17) | 4 (6.78) | 49 (83.05) |
| DHS group | 53 | 12 (22.64) | 17 (32.08) | 13 (24.53) | 11 (20.75) | 29 (54.72) |
|
| — | — | — | — | — | 10.600 |
|
| — | — | — | — | — | 0.001 |
Abbreviation: PFNA: proximal femoral nail antirotation; DHS: dynamic hip screw group.
Comparison of hip function scores before and after operation in the two groups (x ± sd).
| Groups |
| Before operation | After operation |
|---|---|---|---|
| PFNA group | 59 | 45.50 ± 6.49 | 80.73 ± 9.20∗ |
| DHS group | 53 | 44.73 ± 7.89 | 64.19 ± 8.12∗ |
|
| — | 0.566 | 10.040 |
|
| — | 0.572 | <0.001 |
Note: ∗ indicated P < 0.05 compared with that before operation. PFNA: proximal femoral nail antirotation; DHS: dynamic hip screw group.
Figure 1Hip joint function scores before and after operation in PFNA group and DHS group. There was no significant difference in the hip function score between PFNA group and DHS group before operation (P > 0.05), but the hip function score increased significantly after different operations (P < 0.05), and the increase in PFNA group was more significant. Note: ∗ indicated P < 0.05 compared with that before operation; # indicated P < 0.05 compared with PFNA group after operation. PFNA: proximal femoral nail antirotation; DHS: dynamic hip screw group.
VAS scores of hip pain before and after operation in the two groups (x ± sd).
| Groups |
| Before operation | After operation |
|---|---|---|---|
| PFNA group | 59 | 6.24 ± 2.86 | 1.80 ± 0.27∗ |
| DHS group | 53 | 6.43 ± 2.45 | 2.59 ± 0.21∗ |
|
| — | 0.375 | 17.140 |
|
| — | 0.708 | <0.001 |
Note: ∗ indicated P < 0.05 compared with that before operation. PFNA: proximal femoral nail antirotation; DHS: dynamic hip screw group.
Figure 2Comparison of preoperative quality of life scores between PFNA group and DHS group. There was no statistically significant difference in the quality of life score between PFNA group and DHS group before operation (P > 0.05). After different operations, the quality of life score increased significantly in both groups (P < 0.05), and compared with those before surgery, the quality of life score in PFNA group increased more significantly after operation. Note: ∗ indicated P < 0.05 compared with that before operation; # indicated P < 0.05 compared with PFNA group after operation. PFNA: proximal femoral nail antirotation; DHS: dynamic hip screw group.